322
i
Inno-
case surveillance case definition for adolescents and adults.
MMWR41 (RR-17):1-19:1992, 1993
dor Commissió Interdepartmental de Recerca
vaci6
Technologica program.
1
9. Paton NI, Elia M, Jennings G, WardLC, Griffin GE: Bioelectri-
cal impedance analysis in human immunodeficiency virus-in-
fected patients: Comparison of single frequency with multifre-
quency, spectroscopy, and other novel approaches. Nutrition
14:658-666, 1998
REFERENCES
1
.
MooreRD,ChaissonRE:Naturalhistoryof HIVinfectionintheera
ofcombination antiretroviral therapy. AIDS 13:1933-1942, 1999
2.
Wheeler DA, Gibert CL, Launer CA, et al:
loss as
a
20. Valtueña S, Salas-Salvad6J, LordaPG:Therespiratoryquotient
as factor in
rebound. Int J Obes 21:267-
Weight
of survival and disease
in HIV infection.
a
predictor
Terry Beirn Community Programs for Clinical Research on
AIDS.
ImmuneDefic SyndrHumRetrovirol 18:80-85,
998
progression
prognostic
weight-loss
273, 1997
J
21.
Van Loan
Van Itallie
Acquir
Segal KR,
M, Fitzgerald PI, Hodgdon JA,
1
TB:
mass
Leanbody
estimationbybioelectrical
anal-
impedance
J Clin Nutr47:7-14,
3
.
.
Grunfeld C: The wasting syndrome in AIDS: Mechanisms and
ysis :
A
four-site cross-validation study. Am
implications. Nutrition 14:867-868, 1998
1988
4
Macallan DC: Wasting in HIVinfection and AIDS.
J
Nutr 129:
2
2. Salas-Salvadó J, Molina J, Figueras J, Massó C, Marti-Hen-
2
38S-242S,1999
neberg C, Jiménez R: Effect ofthe quality ofinfused energy on
5
.
Melchior JC, Salmon D,
D, et al:
Rigaud
Restingenergy expen-
substrate utilization in the newborn
total parenteral
receiving
nutrition (TPN). Pediatr Res 33:112-117, 1993
3. WeirJB de V: Newmethods for calculating metabolic rate with
Physiol 109:1-9, 1949
diture is increased in stable, malnourished HIV-infected
Am
Sharpstone DR, Murray CP, Ross HM, et al:
J
Clin Nutr 53:437-441, 1991
patients.
2
2
6
.
.
balance in
Energy
special reference to protein metabolism.
J
HIVinfection. AIDS 10:1377-1384, 1996
asymptomatic
4. RozaAM, Schizgal HM:TheHarris Benedict equation re-evalu-
7
S, Corcoran C, Miller K, et al: Determinants of
Grinspoon
ated: resting energy requirement and the body cell mass. Am
Clin Nutr 40:168-182, 1984
J
increased energyexpenditurein HIV-infectedwomen.Am
JClin
Nutr 68:720-725, 1998
2
5. Elborn S, Cordon SM, Western PJ, MacDonald IA, Shale DJ:
Tumor necrosis factor-α resting energy expenditure and
cachexia in cystic fibrosis. Clin Sci 85:563-568, 1993
8
.
.
KotlerDP, TierneyAR, BrennerSK, Couture S, WangJ, Pierson
RNJr: Preservation of short-term energy balance in clinically
stable patients with AIDS. Am
J Clin Nutr 51:7-13, 1990
9
MacallanDC,NobleC, BaldwinC, et al: Energyexpenditureand
Engl
26. Grunfeld C, Kotler DP: Wasting in the acquired immunodefi-
wasting in human immunodeficiency
virus infection.
N
SeminLiver Dis 12:175-187, 1992
ciency syndrome.
J
Med333:83-88, 1995
27. Grunfeld
C, Pang M, Doerrler W, Shigenaga JK,
KR:
Jensen
P,
1
0. Melchior JC, Raguin G, Boulier A, et al: Resting energy expen-
and
Feingold
cytokines
Lipids, lipoproteins, tryglyceride clearance,
diturein humanimmunodeficiencyvirus-infectedpatients: Com-
in human
virus infection and the
Clin Endocrinol Metab
immunodeficiency
betweenpatientswithandwithoutsecondary
parison
Clin Nutr 57:614-619, 1993
infections.
J
AcquiredImmunodeficiencySyndrome.
4:1045-1052, 1992
8. LandmanD, SaraiA, SatheSS: Use
Am
J
7
1
1
1
1. Sharpstone DR, Ross HM, Gazzard BG: The metabolic response
to opportunistic infections in AIDS. AIDS 10:1529-1533, 1996
2. Kotler DP: Human immunodeficiency virus-related wasting:
malabsorption syndromes. Semin Oncol 25:70-75, 1998
2
2
therapyfor
of pentoxifylline
with AIDS-related wasting: Pilot studies. Clin Infect
patients
Dis 18:97-99, 1994
9. Reyes-Teran G, Sierra-Madero JG, Martinez del Cerro V, et al:
3.
K, Tai VW, Schambelan M:
in
Mulligan
Energy expenditure
Med336:70-
Effects of thalidomide on HIV-associated wasting syndrome:
A
humanimmunodeficiencyvirus infection.
N
J
Engl
randomized, double-blind, placebo-controlled clinical trial. AIDS
10:1501-1507, 1996
1
1
1
4. Long CL, Schaffel N, Geiger JW, Schiller WR, Blackemore WS:
Metabolic response to injury and illness: Estimation of energy
30. Jacobson JM, Greenspan JS, Spritzler J, et al: Thalidomide for
and protein needs from indirect calorimetry and
ance. JPEN3:452-456, 1979
nitrogen bal-
the treatment of oral
ulcers in patients with human
aphthous
immunodeficiency
virus infection. National Institute of
Allergy
5. Roubenoff R, Roubenoff RA, Cannon JG, et al: Rheumatoid
and Infectious Diseases AIDS Clinical Trials
J
N
Engl
Group.
cachexia:
Med 336:1487-1493, 1997
Cytokine-driven hypermetabolism accompanying
reduced body cell mass in chronic inflammation.
J Clin Invest
3
1. Strassman G, Fong M, Kenney JS, Jacob CO: Evidence for the
involvement of interleukin Clin
Invest 1992
9
3:2379-2386, 1994
6
in
experimental cachexia.
J
6. Staal-van den Brekel AJ, Dentener MA, Schols AM, Buurman
89:1681-1684,
WA, Wouters EF: Increased resting energy expenditure and
3
3
2. Jebb SA: Energy metabolism in cancer and humanimmunode-
weight loss are related to
a
systemic inflammatory response
in
virus infection. Proc Nutr Soc 56:763-775, 1997
ficiency
lung cancer patients.
J
Clin Oncol 13:2600-2605, 1995
7. Chang HR, Dulloo AG, Bistrian BR: Role of cytokines in AIDS
wasting. Nutrition 14:853-863, 1998
3.
MJ, Garcia-Lorda P, Alonso-Villaverde C, et
Jiménez-Expósito
1
al: Effect of malabsorption on nutritional status and resting
energy expenditure in HIV infected patients. AIDS 12:1965-
1
8. CentersfortheDiseaseControl: Revisedclassification systemfor
human immunodeficiency virus infection and expanded AIDS
1972, 1998